2026 Miami GU Oncology Summit

Accreditation: 5.00 Nursing Contact Hours | 5.00 ABIM MOC II | 5.00 AMA PRA Category 1 Credit™ | 5.00 ACPE Pharmacy

Venue: Hyatt Regency Miami, 400 Southeast 2nd Street, Miami, FL, 33131, United States

Start Date: November 14, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

30+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binaytara

Rohan Garje, MD

Conference Co-Chair

Baptist Health Herbert Wertheim Cancer Institute

Bruno R Bastos, MD

Conference Co-Chair

Mount Sinai Medical Center

Arnab Basu, MBBS, MPH

Planning Committee

Mayo Clinic

Leonardo D. Borregales, MD

Planning Committee

Mount Sinai Medical Center

Brandon Mahal, MD

Planning Committee

University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL, USA

Faculty

Rohan Garje, MD

Session Chair

Baptist Health Herbert Wertheim Cancer Institute

Daniel Vilarim Araujo, MD

Session Chair

University of Florida

Manuel Ozambela, MD

Session Chair

Baptist Health Herbert Wertheim Cancer Institute

Michael Carducci, MD

Session Chair

John Hopkins University

Alena Karotkina, APRN

Session Chair

Mount Sinai Medical Center

Kristine Landrian, DO

Session Chair

Mount Sinai Medical Center

Jordan Alana Ciuro, MD

Topic Presenter

Emory Winship Cancer Institute

Rohit Jain, MD

Topic Presenter

Weill Cornell Medicine/New York-Presbyterian Hospital

Umang Swami, MD

Topic Presenter

Huntsman Cancer Institute

Ulka Vaishampayan, MD

Topic Presenter

University of Michigan

Janaki Sharma, MD

Topic Presenter

Sylvester Cancer Center, Univ of Miami

Leslie V Castaneda, MPH

Topic Presenter

Baptist Health Herbert Wertheim Cancer Institute

Isabel Houlzet, PharmD

Topic Presenter

Mount Sinai Medical Center

Jingsong Zhang, MD, PhD

Topic Presenter

Moffitt Cancer Center

Tianshi Liu, MD

Topic Presenter

Moffitt Cancer Center

Spencer Henick Bachow, MD

Topic Presenter

Baptist Health Herbert Wertheim Cancer Institute

Indraneel Banerjee, MD, MBBS

Topic Presenter

UF Health Jacksonville

Rafael Arteta-Bulos, MD

Topic Presenter

Cleveland Clinic Weston Hospital

Vinay Minocha, MD

Panelist

University of Miami

Jan Krzysztof Rudzinski, MD

Panelist

Baptist Health Herbert Wertheim Cancer Institute

Raju Vaddepally, MD

Panelist

Florida Cancer Specialists & Research Institute

Agenda

Saturday, November 14th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

07:00 AM - 08:00 AMBreakfast, Registration & Exhibits

08:00 AM - 08:05 AMWelcome

08:05 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities (Non-CME Accredited)

08:30 AM - 09:50 AMSession 1: Management of Newly Diagnosed mAPMN (mCSPC) Prostate Cancer

Session Chair: Rohan Garje, MD; Michael Carducci, MD

08:30 AM - 08:45 AM

The case for upfront PSMA radioligand therapy: Should Pluvicto become the first-line standard for all PSMA-positive prostate cancer? – Jordan Alana Ciuro, MD

08:45 AM - 09:00 AM

The case for chemotherapy intensification: When is ADT + ARPI + docetaxel the preferred first-line triplet in mAPMN/S prostate cancer? – Janaki Sharma, MD

09:00 AM - 09:15 AM

Case Presentation: Upfront PARP inhibition in mAPMN/S prostate cancer: Is BRCA2 the defining biomarker, and who benefits beyond it? – Umang Swami, MD

09:15 AM - 09:30 AM

Case Presentation: Capivasertib + abiraterone + ADT in PTEN-deficient mAPMN/S prostate cancer: Defining the ideal candidate? – Jingsong Zhang, MD, PhD

09:30 AM - 09:50 AM

Case-Based Panel Discussion

Moderators:

Rohan Garje, MD; Michael Carducci, MD

Panelists:

Vinay Minocha, MD

09:50 AM - 11:10 AMSession 2: Renal Cell Carcinoma — State of the Art

Session Chair: Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

09:50 AM - 10:05 AM

Case Presentation: The localized renal mass: Surgery, ablation, radiation, or surveillance?

10:05 AM - 10:20 AM

Case Presentation: Adjuvant therapy after nephrectomy: Who should we treat and with what? – Ulka Vaishampayan, MD

10:20 AM - 10:35 AM

Case Presentation: Metastatic disease: Choosing first-line therapy in clear-cell non–clear-cell – Tianshi Liu, MD

10:35 AM - 10:50 AM

Case Presentation: Non–clear-cell RCC: Histology, molecular drivers, and treatment selection – Rafael Arteta-Bulos, MD

10:50 AM - 11:10 AM

Case-Based Panel Discussion

Moderators:

Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

Panelists:

Raju Vaddepally, MD

11:10 AM - 11:25 AMBreak & Exhibits

11:25 AM - 12:45 PMSession 3: Bladder Cancer

Session Chair: Arnab Basu, MBBS, MPH; Manuel Ozambela, MD

11:25 AM - 11:40 AM

Case Presentation: Updates in the management of NMIBC – Indraneel Banerjee, MD, MBBS

11:40 AM - 11:55 AM

Case Presentation: Perioperative systemic therapy for MIBC — a moving target – Rohit Jain, MD

11:55 AM - 12:10 PM

Case Presentation: Front line treatment of metastatic urothelial carcinoma

12:10 PM - 12:25 PM

Case Presentation: Treatment options after EVP – Spencer Henick Bachow, MD

12:25 PM - 12:45 PM

Case-Based Panel Discussion

Moderators:

Arnab Basu, MBBS, MPH; Manuel Ozambela, MD

Panelists:

Jan Krzysztof Rudzinski, MD

12:45 PM - 01:30 PM Lunch & Exhibits

01:30 PM - 02:35 PMSession 4: Symptom Management, Survivorship & Well-Being

Session Chair: Alena Karotkina, APRN; Kristine Landrian, DO

01:30 PM - 01:45 PM

Case Presentation: Symptom management – Kristine Landrian, DO

01:45 PM - 02:00 PM

Case presentation: Drug interaction – Isabel Houlzet, PharmD

02:00 PM - 02:15 PM

Case Presentation: Role of research coordinator in clinical trials – Leslie V Castaneda, MPH

02:15 PM - 02:35 PM

Case-Based Panel Discussion

Moderators:

Kristine Landrian, DO; Alena Karotkina, APRN

02:35 PM - 02:40 PMAdjourn

About 2026 Miami GU Oncology Summit

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship